Functional Redundancy of GSK-3α and GSK-3β in Wnt/β-Catenin Signaling Shown by Using an Allelic Series of Embryonic Stem Cell Lines

Developmental Cell

Volumn 12, Issue 6, 2007, Pages 957-971

  Doble, Bradley W ^a   Patel, Satish ^a   Wood, Geoffrey A ^a   Kockeritz, Lisa K ^a   Woodgett, James R ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

SIGNALING; STEMCELL

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; T CELL FACTOR PROTEIN; WNT PROTEIN;

ALLELE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GENE DOSAGE; GENE FUNCTION; GENETIC TRANSCRIPTION; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REDUNDANCY ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BETA CATENIN; CELL LINE; CYTOSOL; EMBRYO; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOGEN SYNTHASE KINASE 3; GREEN FLUORESCENT PROTEINS; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELLS; WNT PROTEINS;

MAMMALIA;

EID: 34249311572     PISSN: 15345807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.devcel.2007.04.001     Document Type: Article

References (51)

1. Amit S., Hatzubai A., Birman Y., Andersen J.S., Ben-Shushan E., Mann M., Ben-Neriah Y., and Alkalay I. Axin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev. 16 (2002) 1066-1076
2. Arnold S.J., Stappert J., Bauer A., Kispert A., Herrmann B.G., and Kemler R. Brachyury is a target gene of the Wnt/β-catenin signaling pathway. Mech. Dev. 91 (2000) 249-258
3. Aubert J., Dunstan H., Chambers I., and Smith A. Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation. Nat. Biotechnol. 20 (2002) 1240-1245
4. Bain J., McLauchlan H., Elliott M., and Cohen P. The specificities of protein kinase inhibitors: an update. Biochem. J. 371 (2003) 199-204
5. Ben-Shushan E., Thompson J.R., Gudas L.J., and Bergman Y. Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol. Cell. Biol. 18 (1998) 1866-1878
6. Bugeon L., Syed N., and Dallman M.J. A fast and efficient method for transiently transfecting ES cells: application to the development of systems for conditional gene expression. Transgenic Res. 9 (2000) 229-232
7. Cartwright P., McLean C., Sheppard A., Rivett D., Jones K., and Dalton S. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132 (2005) 885-896
8. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., and Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113 (2003) 643-655
9. Choi J., Park S.Y., Costantini F., Jho E.H., and Joo C.K. Adenomatous polyposis coli is down-regulated by the ubiquitin-proteasome pathway in a process facilitated by Axin. J. Biol. Chem. 279 (2004) 49188-49198
10. Ding V.W., Chen R.H., and McCormick F. Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling. J. Biol. Chem. 275 (2000) 32475-32481
11. Doble B.W., and Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116 (2003) 1175-1186
12. Eisenberg L.M., and Eisenberg C.A. Wnt signal transduction and the formation of the myocardium. Dev. Biol. 293 (2006) 305-315
13. Embi N., Rylatt D.B., and Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107 (1980) 519-527
14. Frame S., and Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359 (2001) 1-16
15. Gu H., Zou Y.R., and Rajewsky K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73 (1993) 1155-1164
16. Haegele L., Ingold B., Naumann H., Tabatabai G., Ledermann B., and Brandner S. Wnt signalling inhibits neural differentiation of embryonic stem cells by controlling bone morphogenetic protein expression. Mol. Cell. Neurosci. 24 (2003) 696-708
17. Hagen T., Di Daniel E., Culbert A.A., and Reith A.D. Expression and characterization of GSK-3 mutants and their effect on beta-catenin phosphorylation in intact cells. J. Biol. Chem. 277 (2002) 23330-23335
18. Herrmann B.G., Labeit S., Poustka A., King T.R., and Lehrach H. Cloning of the T gene required in mesoderm formation in the mouse. Nature 343 (1990) 617-622
19. Hoeflich K.P., Luo J., Rubie E.A., Tsao M.S., Jin O., and Woodgett J.R. Requirement for glycogen synthase kinase-3beta in cell survival and NF-κB activation. Nature 406 (2000) 86-90
20. Jho E.H., Zhang T., Domon C., Joo C.K., Freund J.N., and Costantini F. Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 22 (2002) 1172-1183
21. Kielman M.F., Rindapaa M., Gaspar C., van Poppel N., Breukel C., van Leeuwen S., Taketo M.M., Roberts S., Smits R., and Fodde R. Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling. Nat. Genet. 32 (2002) 594-605
22. Kim K., Pang K.M., Evans M., and Hay E.D. Overexpression of β-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. Mol. Biol. Cell 11 (2000) 3509-3523
23. Kuma Y., Campbell D.G., and Cuenda A. Identification of glycogen synthase as a new substrate for stress-activated protein kinase 2b/p38β. Biochem. J. 379 (2004) 133-139
24. Leung J.Y., Kolligs F.T., Wu R., Zhai Y., Kuick R., Hanash S., Cho K.R., and Fearon E.R. Activation of AXIN2 expression by β-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J. Biol. Chem. 277 (2002) 21657-21665
25. Lian J.B., Stein G.S., Javed A., van Wijnen A.J., Stein J.L., Montecino M., Hassan M.Q., Gaur T., Lengner C.J., and Young D.W. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev. Endocr. Metab. Disord. 7 (2006) 1-16
26. Lickert H., Domon C., Huls G., Wehrle C., Duluc I., Clevers H., Meyer B.I., Freund J.N., and Kemler R. Wnt/(β)-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine. Development 127 (2000) 3805-3813
27. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., and He X. Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108 (2002) 837-847
28. Lohnes D. The Cdx1 homeodomain protein: an integrator of posterior signaling in the mouse. Bioessays 25 (2003) 971-980
29. Lustig B., Jerchow B., Sachs M., Weiler S., Pietsch T., Karsten U., van de Wetering M., Clevers H., Schlag P.M., Birchmeier W., et al. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell. Biol. 22 (2002) 1184-1193
30. McManus E.J., Sakamoto K., Armit L.J., Ronaldson L., Shpiro N., Marquez R., and Alessi D.R. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J. 24 (2005) 1571-1583
31. Meijer L., Flajolet M., and Greengard P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol. Sci. 25 (2004) 471-480
32. Mitsiades C.S., Mitsiades N., and Koutsilieris M. The Akt pathway: molecular targets for anti-cancer drug development. Curr. Cancer Drug Targets 4 (2004) 235-256
33. Paling N.R., Wheadon H., Bone H.K., and Welham M.J. Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J. Biol. Chem. 279 (2004) 48063-48070
34. Rosner M.H., Vigano M.A., Ozato K., Timmons P.M., Poirier F., Rigby P.W., and Staudt L.M. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345 (1990) 686-692
35. Ruel L., Bourouis M., Heitzler P., Pantesco V., and Simpson P. Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch. Nature 362 (1993) 557-560
36. Salahshor S., and Woodgett J.R. The links between axin and carcinogenesis. J. Clin. Pathol. 58 (2005) 225-236
37. Salic A., Lee E., Mayer L., and Kirschner M.W. Control of β-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol. Cell 5 (2000) 523-532
38. Salingcarnboriboon R., Tsuji K., Komori T., Nakashima K., Ezura Y., and Noda M. Runx2 is a target of mechanical unloading to alter osteoblastic activity and bone formation in vivo. Endocrinology 147 (2006) 2296-2305
39. Sato N., Meijer L., Skaltsounis L., Greengard P., and Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10 (2004) 55-63
40. Siegfried E., Chou T.B., and Perrimon N. wingless signaling acts through zeste-white 3, the Drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fate. Cell 71 (1992) 1167-1179
41. Skurat A.V., and Dietrich A.D. Phosphorylation of Ser640 in muscle glycogen synthase by DYRK family protein kinases. J. Biol. Chem. 279 (2004) 2490-2498
42. Stevens L.C. The biology of teratomas. Adv. Morphog. 6 (1967) 1-31
43. Storm M.P., Bone H.K., Beck C.G., Bourillot P.Y., Schreiber V., Damiano T., Nelson A., Savatier P., and Welham M.J. Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells. J. Biol. Chem. 282 (2007) 6265-6273
44. Suzuki A., Raya A., Kawakami Y., Morita M., Matsui T., Nakashima K., Gage F.H., Rodriguez-Esteban C., and Belmonte J.C. Maintenance of embryonic stem cell pluripotency by Nanog-mediated reversal of mesoderm specification. Nat. Clin. Pract. Cardiovasc. Med. 3 Suppl 1 (2006) S114-S122
45. Toumadje A., Kusumoto K., Parton A., Mericko P., Dowell L., Ma G., Chen L., Barnes D.W., and Sato J.D. Pluripotent differentiation in vitro of murine ES-D3 embryonic stem cells. In Vitro Cell. Dev. Biol. 39 (2003) 449-453
46. van Noort M., and Clevers H. TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev. Biol. 244 (2002) 1-8
47. Veeman M.T., Slusarski D.C., Kaykas A., Louie S.H., and Moon R.T. Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr. Biol. 13 (2003) 680-685
48. Watanabe S., Umehara H., Murayama K., Okabe M., Kimura T., and Nakano T. Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene 25 (2006) 2697-2707
49. Woodgett J.R. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9 (1990) 2431-2438
50. Yamaguchi T.P., Takada S., Yoshikawa Y., Wu N., and McMahon A.P. T (Brachyury) is a direct target of Wnt3a during paraxial mesoderm specification. Genes Dev. 13 (1999) 3185-3190
51. Zeng X., Tamai K., Doble B., Li S., Huang H., Habas R., Okamura H., Woodgett J., and He X. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438 (2005) 873-877